Vinge has advised Xpray Pharma in connection with share issue
November 08, 2021
Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of approximately SEK 100 million.
In the beginning of November, the European Commission put forward a proposal regarding a framework to accelerate the deployment of renewable energy, with the ambition to speed up the transition to green energy and reduce the EU’s dependency on Russian fossil fuels. In line with the conclusions of the European Council at the end of October, the European Commission considers that the ongoing energy crisis requires immediate action to transpose parts of the REPowerEU plan, and therefore proposes to adopt a Council Regulation using Article 122(1) of the Treaty of the Functioning of the European Union (TFEU) as legal basis.
In May 2022, the Commission presented its proposal regarding REPowerEU. The purpose of the plan, which is based on the "Fit for 55" parcel , is to change Europe’s energy system by eliminating the EU’s dependency on Russian fossil fuels as well as to tackle the climate crisis. The European Parliament and the Council have now adopted their positions in order to incorporate the plan into the national recovery and resilience plans.
International companies run the risk of the erroneous management of tax issues when conducting operations in several jurisdictions. In such event, disputes can arise with the relevant tax authorities. The Legal 500 has now introduced a dedicated chapter on tax disputes in its comparative guide for the first time and Ulrika Bengtsson, advokat and counsel, has been selected to provide a clear picture of the Swedish tax litigation system.